menu search
Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s
03/06/2023 20:00

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s
03/06/2023 20:00

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s
03/06/2023 20:00

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s
03/06/2023 20:00

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s
03/06/2023 20:00

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s
03/06/2023 20:00

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s
03/06/2023 20:00

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

: ‘ability is ageless’: new york city helps retirees get back to work and fill open jobs
03/06/2023 19:35

: ‘ability is ageless’: new york city helps retirees get back to work and fill open jobs

A new program trains New York retirees to rejoin the workforce. Read Full Story The post : ‘Ability is ageless’: New York City helps retirees get ...

Rosen, a leading law firm, encourages wheels up experience inc. investors with losses to secure counsel before important deadline in securities class action filed by the firm – up
03/06/2023 19:33

Rosen, a leading law firm, encourages wheels up experience inc. investors with losses to secure counsel before important deadline in securities class action filed by the firm – up

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Wheels Up...

Rosen, a global and leading law firm, encourages virtu financial, inc. investors with losses to secure counsel before important deadline in securities class action – virt
03/06/2023 19:30

Rosen, a global and leading law firm, encourages virtu financial, inc. investors with losses to secure counsel before important deadline in securities class action – virt

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Virtu Financi...

: beyond openai: 7 promising startups that have saved lives, sped up drug development and improved manufacturing
03/06/2023 19:19

: beyond openai: 7 promising startups that have saved lives, sped up drug development and improved manufacturing

OpenAI is stealing the spotlight as the definitive AI startup, but other promising startups are making waves and generating buzz in Silicon Valley and...

Janelle monae announces ‘age of pleasure’ north american tour
03/06/2023 19:00

Janelle monae announces ‘age of pleasure’ north american tour

Critically acclaimed and award-winning singer and actress has announced her “Age of Pleasure Tour” across North America. Read Full Story The post ...

Rosen, respected investor counsel, encourages pdd holdings inc. f/k/a pinduoduo inc. investors with losses to inquire about securities class action investigation – pdd
03/06/2023 18:18

Rosen, respected investor counsel, encourages pdd holdings inc. f/k/a pinduoduo inc. investors with losses to inquire about securities class action investigation – pdd

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...

Biden signs debt ceiling bill that pulls u.s. back from brink of default
03/06/2023 18:17

Biden signs debt ceiling bill that pulls u.s. back from brink of default

Biden signs debt ceiling bill that pulls U.S. back from brink of default Read Full Story The post Biden signs debt ceiling bill that pulls U.S. back f...

Cogent biosciences announces positive lead-in data from ongoing phase 3 peak trial evaluating bezuclastinib in combination with sunitinib in patients with gastrointestinal stromal tumors (gist)
03/06/2023 18:15

Cogent biosciences announces positive lead-in data from ongoing phase 3 peak trial evaluating bezuclastinib in combination with sunitinib in patients with gastrointestinal stromal tumors (gist)

– Data presented at ASCO annual meeting demonstrate 55% Disease Control Rate (DCR) in heavily pre-treated GIST patients, including 100% DCR and 17% ...

Replimune presents rp1 data from the ignyte anti-pd1 failed melanoma cohort and rp2 data in uveal melanoma at the 2023 american society of clinical oncology (asco) annual meeting
03/06/2023 18:15

Replimune presents rp1 data from the ignyte anti-pd1 failed melanoma cohort and rp2 data in uveal melanoma at the 2023 american society of clinical oncology (asco) annual meeting

Updated data from ongoing IGNYTE anti-PD1 failed melanoma cohort shows RP1 combined with nivolumab continues to demonstrate deep and durable responses...

‘lung detoxes’ are the tiktok myth of the week
03/06/2023 18:14

‘lung detoxes’ are the tiktok myth of the week

But instead of taking TikTok breath-holding tests, the American Lung Association suggests you see your doctor if you notice shortness of breath, cough...

Bitmex co-founder lists reasons for bitcoin’s mild reaction to us banking crisis
03/06/2023 18:14

Bitmex co-founder lists reasons for bitcoin’s mild reaction to us banking crisis

BitMEX co-founder Arthur Hayes published a blog post titled “Patience is Beautiful,” shedding light on Bitcoin. Read Full Story The post BitMEX Co...

Your guide to medications for coronary artery disease
03/06/2023 17:59

Your guide to medications for coronary artery disease

Several medications help treat and prevent coronary artery disease (CAD). This includes statins to lower cholesterol levels, ACE inhibitors to lower b...

Gold rebounds as debt deal optimism weighs on dollar, yields
03/06/2023 17:44

Gold rebounds as debt deal optimism weighs on dollar, yields

Gold prices held close to a two-month low on Tuesday as a U.S. debt ceiling deal and reduced bets for a pause in rate hikes in June dented the metal�...

Gold price reaches record high
03/06/2023 17:44

Gold price reaches record high

According to the Federation of Nepal Gold and Silver Dealers Association, the price of fine gold has reached the highest level of Rs 112,500 today. On...

Usd/cad weekly outlook: markets lean towards fed’s pause
03/06/2023 17:35

Usd/cad weekly outlook: markets lean towards fed’s pause

The dollar lost its safe-haven appeal as the US averted a debt default. Money markets currently assign a probability of around 29% for a June Fed hike...

This week in coins: xrp, litecoin and solana outpace bitcoin in week of small gains
03/06/2023 16:59

This week in coins: xrp, litecoin and solana outpace bitcoin in week of small gains

Markets managed to finally overcome four weeks of inertia and grow a little this week, but perennial leaders Bitcoin and Ethereum remained virtually f...

Virt class action reminder: kessler topaz meltzer & check, llp reminds virtu financial, inc. investors of securities fraud class action lawsuit
03/06/2023 16:59

Virt class action reminder: kessler topaz meltzer & check, llp reminds virtu financial, inc. investors of securities fraud class action lawsuit

RADNOR, Pa., June 03, 2023 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities ...

Medvet columbus dedicates dr. william d. dehoff surgery center
03/06/2023 16:55

Medvet columbus dedicates dr. william d. dehoff surgery center

WORTHINGTON, Ohio, June 03, 2023 (GLOBE NEWSWIRE) — MedVet, a leader in emergency and specialty veterinary healthcare, dedicated the MedVet Columbus...

Brazil’s crypto exchange mercado bitcoin licensed as payment provider: report
03/06/2023 16:44

Brazil’s crypto exchange mercado bitcoin licensed as payment provider: report

Cryptocurrency exchange Mercado Bitcoin was granted a payment provider license from Brazil’s central bank on June 2, according to local media report...

Rosen, a leading law firm, encourages triplepoint venture growth bdc corp. investors with losses to inquire about securities class action investigation – tpvg
03/06/2023 16:28

Rosen, a leading law firm, encourages triplepoint venture growth bdc corp. investors with losses to inquire about securities class action investigation – tpvg

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...

Ys investor news: rosen, skilled investor counsel, encourages ys biopharma co., ltd. f/k/a summit healthcare acquisition corp. investors to inquire about securities class action investigation – ys, sm
03/06/2023 16:25

Ys investor news: rosen, skilled investor counsel, encourages ys biopharma co., ltd. f/k/a summit healthcare acquisition corp. investors to inquire about securities class action investigation – ys, sm

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...

Ys investor news: rosen, skilled investor counsel, encourages ys biopharma co., ltd. f/k/a summit healthcare acquisition corp. investors to inquire about securities class action investigation – ys, sm
03/06/2023 16:25

Ys investor news: rosen, skilled investor counsel, encourages ys biopharma co., ltd. f/k/a summit healthcare acquisition corp. investors to inquire about securities class action investigation – ys, sm

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...

Ys investor news: rosen, skilled investor counsel, encourages ys biopharma co., ltd. f/k/a summit healthcare acquisition corp. investors to inquire about securities class action investigation – ys, sm
03/06/2023 16:25

Ys investor news: rosen, skilled investor counsel, encourages ys biopharma co., ltd. f/k/a summit healthcare acquisition corp. investors to inquire about securities class action investigation – ys, sm

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...

Ys investor news: rosen, skilled investor counsel, encourages ys biopharma co., ltd. f/k/a summit healthcare acquisition corp. investors to inquire about securities class action investigation – ys, sm
03/06/2023 16:25

Ys investor news: rosen, skilled investor counsel, encourages ys biopharma co., ltd. f/k/a summit healthcare acquisition corp. investors to inquire about securities class action investigation – ys, sm

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...

Ys investor news: rosen, skilled investor counsel, encourages ys biopharma co., ltd. f/k/a summit healthcare acquisition corp. investors to inquire about securities class action investigation – ys, sm
03/06/2023 16:25

Ys investor news: rosen, skilled investor counsel, encourages ys biopharma co., ltd. f/k/a summit healthcare acquisition corp. investors to inquire about securities class action investigation – ys, sm

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...

Ys investor news: rosen, skilled investor counsel, encourages ys biopharma co., ltd. f/k/a summit healthcare acquisition corp. investors to inquire about securities class action investigation – ys, sm
03/06/2023 16:25

Ys investor news: rosen, skilled investor counsel, encourages ys biopharma co., ltd. f/k/a summit healthcare acquisition corp. investors to inquire about securities class action investigation – ys, sm

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...

Eurusd technical levels in play for the week starting june 5th
03/06/2023 16:21

Eurusd technical levels in play for the week starting june 5th

Greg Michalowski of Forexlive.com takes a deep into the technicals defining the bias, risk and key targets for the EURUSD heading into the new trading...

The nzdusd buyers tried to extend higher, but failed. what now?
03/06/2023 16:21

The nzdusd buyers tried to extend higher, but failed. what now?

The buyers in the NZDUSD tried to break higher on Friday, moving above a key 200 hour MA on the hourly chart and swing level on the daily chart. Howev...


Search within

Pages Search Results: